The FDA’s post-market medical device cybersecurity plans and procedures don’t go far enough to protect public health in the face of cyber-threats, according to an OIG audit. The FDA, in response, has agreed with the OIG’s recommendations.
OIG: FDA’s post-market cybersecurity policies and procedures are lacking
